Pritelivir

The trial was suspended by fda for possible toxicity issues; aicuris terminated the trial to unblind the study. Everyone involved with the study was supprised by the fda's actions since the trial required to be on the medication for four weeks. The fda pointed to animal studies that involved 20 times the doses involved in the study. Aicuris is trying to resolve their real or imaginary concerns.